Sponsor Pipeline

Relmada Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07464145 A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With… Bladder (Urothelial, Transitional Cell) Cancer Not Yet Recruiting
Phase 2
NCT06663137 Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC Non Muscle Invasive Bladder Cancer Recruiting
Disease Areas
Bladder Cancer (2)
Get alerts when Relmada Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free